With a €2 billion valuation on the stock market and annual revenues of €1.2 billion, UDG Healthcare has the financial muscle to weather a storm. Plus, as the firm’s chief executive Brendan McAtamney acknowledges, with life expectancy and demographics increasing, UDG is operating in a safe harbor industry. The Dublin-based healthcare service provider employs 9,000 people in 29 countries and is organised across two divisions. The first, Sharp, is a global leader in contract clinical, manufacturing, packaging, and technology services. Sharp accounts for 30 per cent of UDG’s profits. The second, Ashfield, provides healthcare advisory, communications, commercial and clinical services,…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .